237 related articles for article (PubMed ID: 27373849)
1. Block of Na(+)/Ca(2+) exchanger by SEA0400 in human right atrial preparations from patients in sinus rhythm and in atrial fibrillation.
Christ T; Kovács PP; Acsai K; Knaut M; Eschenhagen T; Jost N; Varró A; Wettwer E; Ravens U
Eur J Pharmacol; 2016 Oct; 788():286-293. PubMed ID: 27373849
[TBL] [Abstract][Full Text] [Related]
2. The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.
Birinyi P; Tóth A; Jóna I; Acsai K; Almássy J; Nagy N; Prorok J; Gherasim I; Papp Z; Hertelendi Z; Szentandrássy N; Bányász T; Fülöp F; Papp JG; Varró A; Nánási PP; Magyar J
Cardiovasc Res; 2008 Jun; 78(3):476-84. PubMed ID: 18252759
[TBL] [Abstract][Full Text] [Related]
3. Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart.
Farkas AS; Acsai K; Nagy N; Tóth A; Fülöp F; Seprényi G; Birinyi P; Nánási PP; Forster T; Csanády M; Papp JG; Varró A; Farkas A
Br J Pharmacol; 2008 May; 154(1):93-104. PubMed ID: 18332852
[TBL] [Abstract][Full Text] [Related]
4. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation.
Poulet C; Wettwer E; Grunnet M; Jespersen T; Fabritz L; Matschke K; Knaut M; Ravens U
PLoS One; 2015; 10(6):e0131432. PubMed ID: 26121051
[TBL] [Abstract][Full Text] [Related]
5. Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger.
Tanaka H; Namekata I; Takeda K; Kazama A; Shimizu Y; Moriwaki R; Hirayama W; Sato A; Kawanishi T; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):526-34. PubMed ID: 16003546
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological discrimination of plasmalemmal and mitochondrial sodium-calcium exchanger in cardiomyocyte-derived H9c2 cells.
Namekata I; Hamaguchi S; Tanaka H
Biol Pharm Bull; 2015; 38(1):147-50. PubMed ID: 25744471
[TBL] [Abstract][Full Text] [Related]
7. Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias.
Nagy N; Kormos A; Kohajda Z; Szebeni Á; Szepesi J; Pollesello P; Levijoki J; Acsai K; Virág L; Nánási PP; Papp JG; Varró A; Tóth A
Br J Pharmacol; 2014 Dec; 171(24):5665-81. PubMed ID: 25073832
[TBL] [Abstract][Full Text] [Related]
8. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.
Tanaka H; Nishimaru K; Aikawa T; Hirayama W; Tanaka Y; Shigenobu K
Br J Pharmacol; 2002 Mar; 135(5):1096-100. PubMed ID: 11877314
[TBL] [Abstract][Full Text] [Related]
9. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.
Takahashi K; Takahashi T; Suzuki T; Onishi M; Tanaka Y; Hamano-Takahashi A; Ota T; Kameo K; Matsuda T; Baba A
Eur J Pharmacol; 2003 Jan; 458(1-2):155-62. PubMed ID: 12498920
[TBL] [Abstract][Full Text] [Related]
12. Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes.
Birinyi P; Acsai K; Bányász T; Tóth A; Horváth B; Virág L; Szentandrássy N; Magyar J; Varró A; Fülöp F; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):63-70. PubMed ID: 16086157
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies.
Amran MS; Hashimoto K; Homma N
J Pharmacol Exp Ther; 2004 Jul; 310(1):83-9. PubMed ID: 15028781
[TBL] [Abstract][Full Text] [Related]
14. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.
Matsuda T; Koyama Y; Baba A
J Pharmacol Sci; 2005 Mar; 97(3):339-43. PubMed ID: 15764845
[TBL] [Abstract][Full Text] [Related]
15. SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.
Wang J; Zhang Z; Hu Y; Hou X; Cui Q; Zang Y; Wang C
Physiol Res; 2007; 56(1):17-23. PubMed ID: 16497099
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence Analysis of the Mitochondrial Effect of a Plasmalemmal Na
Namekata I; Hamaguchi S; Iida-Tanaka N; Kusakabe T; Kato K; Kawanishi T; Tanaka H
Biol Pharm Bull; 2017; 40(9):1551-1555. PubMed ID: 28867737
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the sodium-calcium exchanger via SEA0400 altered manganese-induced T1 changes in isolated perfused rat hearts.
Chen Y; Payne K; Perara VS; Huang S; Baba A; Matsuda T; Yu X
NMR Biomed; 2012 Nov; 25(11):1280-5. PubMed ID: 22434695
[TBL] [Abstract][Full Text] [Related]
18. SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart.
Szentandrássy N; Birinyi P; Szigeti G; Farkas A; Magyar J; Tóth A; Csernoch L; Varró A; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):65-71. PubMed ID: 18458877
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.
Lee C; Visen NS; Dhalla NS; Le HD; Isaac M; Choptiany P; Gross G; Omelchenko A; Matsuda T; Baba A; Takahashi K; Hnatowich M; Hryshko LV
J Pharmacol Exp Ther; 2004 Nov; 311(2):748-57. PubMed ID: 15231867
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases.
Tóth A; Kiss L; Varró A; Nánási PP
Curr Med Chem; 2009; 16(25):3294-321. PubMed ID: 19548864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
